Soranib contains sorafenib, which is a small molecular inhibitor of several tyrosine protein kinases.
Indication:
Soranib is used for the treatment of primary kidney cancer (advanced renal cell carcinoma) and advanced primary liver cancer.
200 mg tablets.
Note:
Soranib is a prescription drug and should be used under proper medical guidance and advice.